In the News
Livemint | 01.02.2024
Piramal Pharma Q3 FY24 results : profit at ₹10.11Cr, Revenue increased by 14.14% YoY
Business Today | 24.12.2023
MPW 2023: For Piramal Pharma Chairperson Nandini Piramal sustainability is synonymous with growth
Business Today | 11.12.2023
BT MPW 2023: Nandini Piramal says not all companies maintain high standards in Indian pharma
Business Today | 09.12.2023
Infosys founders are an inspiration': Ajay Piramal's daughter and Piramal Pharma chief looks at Nandan Nilekani as an idol
The Financial Express | 08.11.2023
We will focus on revenue growth, cost optimisation, and debt reduction: Nandini Piramal, Chairperson, Piramal Pharma
Business Standard | 07.11.2023
Should touch Rs 1K crore from OTC this year, says Nandini Piramal
The Hindu BusinessLine | 06.11.2023
Recovery and turnaround this year - Piramal Pharma Chairperson
CNBC-TV18 | 28.09.2023
Piramal Pharma's US manufacturing unit successfully completes USFDA inspection
Money Control | 27.09.2023
Piramal Pharma up almost 4% on green signal from US FDA for Bethlehem plant
Business Standard | 08.09.2023
Piramal Pharma is aiming to achieve zero waste to landfill by FY25
Adgully | 11.08.2023
Piramal Consumer Products Division introduces i-activ menstrual cups in their active range
Mint | 08.08.2023
Piramal Pharma rights issue opens today. Price, ratio, other details in five points
CNBC TV18 | 02.08.2023
Piramal Pharma Rights Issue: Record date today, here's all you need to know
The Economic Times | 01.08.2023
Pickup in contract manufacturing biz set to drive growth: Piramal Pharma
Passionate Marketing | 28.06.2023
Piramal Consumer Products division expands the Tetmosol soap brand; introduces the Icy Cool variant
Business Standard | 06.06.2023
Piramal Critical Care appoints US-based Jeffrey Hampton as President, COO
The Economic Times | 26.05.2023
Piramal Pharma may double in a year; 4 metal stocks can give 20% return in 3 months : Sanjiv Bhasin
Mint | 25.05.2023
Earnings Impact: Piramal Pharma soars 13% as company turns profitable in March quarter
Pharmtech | 09.05.2023
Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions
The Economic Times | 09.05.2023
IPL-flavoured portfolio: Smallcase manager Divam Sharma reveals his playing XI stocks
CNBC-TV18 | 18.04.2023
US FDA completes inspection at Piramal Pharma Sellersville manufacturing unit
The Economic Times | 11.04.2023
Hyderabad emerging as life sciences hub, with global and domestic pharmaceutical firms
Free Press Journal | 01.04.2023
US FDA conducts GMP inspection at Piramal Pharma's Digwal facility
The Hindu Business Line | 24.02.2023
Access to capital, regulatory reforms key to boost innovation in pharma industry: CEOs
ET Healthworld | 26.02.2023
Top Pharma CEOs optimistic about future growth opportunities, foresee the rise of India on global stage
The Economic Times | 09.02.2023
Piramal Pharma Q3 Results: Firm reports Rs 90 cr loss, gets board nod to raise up to Rs 1,050 cr
Business Today | 17.01.2023
Piramal Pharma is emerging as a new pharma giant; what's driving the company's growth?
CNBC-TV18 | 14.01.2023
USFDA issues Form-483 with two observations to Piramal Pharma's Sellersville unit
The Economic Times | 11.01.2023
Carlyle buys wellness & beauty co VLCC, pays $275-$300 mn for nearly 70% stake
The Hindu Business Line | 09.01.2023
Pharma’s deal street. Managing bottomlines without losing sight of patient needs
The Economic Times | 19.12.2022
Piramal Pharma expects healthy growth in its key businesses. But does it cure the debt ailment?
Business Standard | 09.11.2022
Piramal Pharma posts Q2 net loss of Rs 37 cr, revenue grows to Rs 1,720 cr
Business Standard | 27.10.2022
MSCI sets aside Piramal Pharma's exclusion from global standard index
Indiainfoline | 25.10.2022
Piramal Pharma to invest Rs1,200 in UK over the next 12 to 18 months
The Economic Times | 25.10.2022
Piramal Pharma to inject funds into expansion, acquisitions
India Education Diary | 20.10.2022
Piramal Pharma Introduces Nixit, Its Smoking Cessation Brand With A New Campaign #QuititwithNixit In Karnataka
Financial Express | 20.10.2022
Piramal Pharma earmarks Rs 1,200 cr capex over next 24 months: Nandini
India Education Diary | 20.10.2022
Piramal Pharma Introduces Nixit, Its Smoking Cessation Brand With A New Campaign #QuititwithNixit In Karnataka
Business Standard | 19.10.2022
We won't make an acquisition just because we have to: Piramal Pharma chief
Business Standard | 19.10.2022
Piramal Pharma ends at Rs 192 on debut, valued at Rs 22,882 cr at close
India Today | 19.10.2022
Yapan Bio Adds New Process Development Facility; Expands Capacity and Capabilities in Large Molecule Therapeutics
Market Screener | 29.09.2022
Piramal Enterprises : Pharma Appoints Vibha Paul Rishi as Non- Executive Director to its Board of Directors
BW Disrupt | 22.09.2022
Piramal Pharma's Consumer Division Introduces D2C Platform Wellify
LinkedIn Feeds